7.92BMarket Cap
LossP/E TTM
Key Figures
46.240Open
46.298High
7.31MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.06%Turnover Ratio
44.290Prev. Close
42.300Low
229.20MTurnover
LossP/E Static
17.77P/B
0.00%Div Yield TTM
-16.47%ROA
104.32052wk High
1.24Volume Ratio
-746.33MNet Profit
180.24MShares
-1.7110EPS TTM
--Beta
-81.58%ROE
41.73052wk Low
9.03%Amplitude
64.13%Gross Margin
7.92BMarket Cap
-6.61Reward/Risk
4.01%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Tempus AI Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 68 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 68.37.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Tempus AI Inc Highlights
StrengthsRisks
Tempus AI Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Tempus AI Inc Info
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Ticker SymbolTEM
CompanyTempus AI Inc
CEOLefkofsky (Eric P)
Websitehttps://investors.tempus.com/
Shareholders
FAQs
What is the current price of Tempus AI Inc (TEM)?
The current price of Tempus AI Inc (TEM) is 43.87.
What is the symbol of Tempus AI Inc?
The ticker symbol of Tempus AI Inc is TEM.
What is the 52-week high of Tempus AI Inc?
The 52-week high of Tempus AI Inc is 104.32.
What is the 52-week low of Tempus AI Inc?
The 52-week low of Tempus AI Inc is 41.73.
What is the market capitalization of Tempus AI Inc?
The market capitalization of Tempus AI Inc is 7.91B.
Is Tempus AI Inc (TEM) currently rated as Buy, Hold, or Sell?
According to analysts, Tempus AI Inc (TEM) has an overall rating of Buy, with a price target of 68.37.
What is the Earnings Per Share (EPS TTM) of Tempus AI Inc (TEM)?
The Earnings Per Share (EPS TTM) of Tempus AI Inc (TEM) is -1.41.